Nephros
NEPHPrivate Company
Total funding raised: $37M
Overview
Nephros is a mission-driven company focused on providing leading technology and resources to advance water quality and safety. Founded with deep roots in the demanding hemodialysis market, it has successfully expanded its proprietary filtration platform to serve broader healthcare infection control and commercial water treatment needs. The company's strategy combines a solutions-based business model with educational resources, positioning it to address growing regulatory and public health concerns over waterborne contaminants.
Technology Platform
Proprietary hollow-fiber membrane microfiltration/ultrafiltration technology, originally developed for hemodialysis and FDA-cleared for removing bacteria, endotoxins, and other microbial contaminants from water.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Faces competition from large medical device firms (e.g., 3M/Pall) in healthcare and major water treatment companies (e.g., Ecolab, Culligan) in commercial markets. Nephros differentiates through its FDA clearances, dialysis-proven technology, and nimble, service-oriented customer support.
Company Timeline
Founded in South Orange, United States
Series A: $12.0M
Series B: $25.0M